AIM: To investigate possible correlations between acute phase proteins (APPs) activation and coronary flow in subjects with coronary artery disease (CAD) undergoing coronary angiography. METHODS: Fifty-nine consecutive patients with CAD who underwent coronary angiography were enrolled in the study: blood samples were taken in order to evaluate plasmatic concentrations of C-reactive protein (CRP) and APPs such as alpha-1-anti-trypsin (A1AT), alpha-1-glyco-protein (A1GP) and haptoglobin (HG). Coronary flow on left anterior descending (LAD) was assessed with TIMI frame count (TFC). Patients with TIMI flow 0-1 were excluded from the study. RESULTS: Coronary atherosclerosis expressed in terms of number of coronary vessels with severe (>70%) lumen narrowing was related to serum concentrations of all considered APPs (A1GP: r 0.282, P < 0.05; A1AT: r 0.256, P 0.055; HG: r 0.335, P < 0.01). TFC on LAD was related to all considered APPs (A1GP: r 0.24, P 0.06; A1AT: r 0.28, P < 0.05; HG: r 0.43, P < 0.01; log CRP: r 0.57, P < 0.001); correlations remained significant even after correction for age, gender, risk factors, diagnosis and treatment. Among 12 patients who were previously treated with coronary angioplasty, those implanted with a drug eluting stent showed a significantly slower coronary flow on LAD (19.6 +/- 2.07 vs. 16.71 +/- 2.06, P < 0.05) if compared with those implanted with a bare metal stent. CONCLUSIONS: An increased inflammatory systemic activation featured by plasmatic concentrations of CRP and APPs might be associated with both coronary atherosclerosis and an impaired coronary micro-circulation.
AIM: To investigate possible correlations between acute phase proteins (APPs) activation and coronary flow in subjects with coronary artery disease (CAD) undergoing coronary angiography. METHODS: Fifty-nine consecutive patients with CAD who underwent coronary angiography were enrolled in the study: blood samples were taken in order to evaluate plasmatic concentrations of C-reactive protein (CRP) and APPs such as alpha-1-anti-trypsin (A1AT), alpha-1-glyco-protein (A1GP) and haptoglobin (HG). Coronary flow on left anterior descending (LAD) was assessed with TIMI frame count (TFC). Patients with TIMI flow 0-1 were excluded from the study. RESULTS:Coronary atherosclerosis expressed in terms of number of coronary vessels with severe (>70%) lumen narrowing was related to serum concentrations of all considered APPs (A1GP: r 0.282, P < 0.05; A1AT: r 0.256, P 0.055; HG: r 0.335, P < 0.01). TFC on LAD was related to all considered APPs (A1GP: r 0.24, P 0.06; A1AT: r 0.28, P < 0.05; HG: r 0.43, P < 0.01; log CRP: r 0.57, P < 0.001); correlations remained significant even after correction for age, gender, risk factors, diagnosis and treatment. Among 12 patients who were previously treated with coronary angioplasty, those implanted with a drug eluting stent showed a significantly slower coronary flow on LAD (19.6 +/- 2.07 vs. 16.71 +/- 2.06, P < 0.05) if compared with those implanted with a bare metal stent. CONCLUSIONS: An increased inflammatory systemic activation featured by plasmatic concentrations of CRP and APPs might be associated with both coronary atherosclerosis and an impaired coronary micro-circulation.
Authors: Mario Gössl; Michael Rosol; Nasser M Malyar; Lorraine A Fitzpatrick; Patricia E Beighley; Mair Zamir; Erik L Ritman Journal: Anat Rec A Discov Mol Cell Evol Biol Date: 2003-06
Authors: C G Schalkwijk; D C Poland; W van Dijk; A Kok; J J Emeis; A M Dräger; A Doni; V W van Hinsbergh; C D Stehouwer Journal: Diabetologia Date: 1999-03 Impact factor: 10.122
Authors: A D Hingorani; J Cross; R K Kharbanda; M J Mullen; K Bhagat; M Taylor; A E Donald; M Palacios; G E Griffin; J E Deanfield; R J MacAllister; P Vallance Journal: Circulation Date: 2000-08-29 Impact factor: 29.690
Authors: Thomas H Schindler; Egbert U Nitzsche; Manfred Olschewski; Nobuhisa Magosaki; Michael Mix; John O Prior; Alvaro D Facta; Ulrich Solzbach; Hanjoerg Just; Heinrich R Schelbert Journal: Circulation Date: 2004-08-16 Impact factor: 29.690
Authors: Stephan Fichtlscherer; Susanne Breuer; Christopher Heeschen; Stefanie Dimmeler; Andreas M Zeiher Journal: J Am Coll Cardiol Date: 2004-07-07 Impact factor: 24.094
Authors: Maciej Cymerys; Paweł Bogdański; Danuta Pupek-Musialik; Anna Jabłecka; Jan Łącki; Izabela Korczowska; Joanna Dytfeld Journal: Med Sci Monit Date: 2012-05
Authors: Tatiana Martin-Rojas; Laura Mourino-Alvarez; Felix Gil-Dones; Fernando de la Cuesta; Esther Rosello-Lleti; Carlos M Laborde; Miguel Rivera; Luis Fernando Lopez-Almodovar; Juan Antonio Lopez; Finn Akerstrom; Luis R Padial; Maria G Barderas Journal: Clin Proteomics Date: 2017-04-21 Impact factor: 3.988